ACRSAclaris Therapeutics, Inc.
6.410USD-0.47%Mkt Cap: 943.54M $P/E: —3d ago
Aclaris Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering and developing novel molecule product candidates for immuno-inflammatory diseases in the United States. The company produ…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap943.54M $
Enterprise Value842.06M $
Revenue (TTM)8.22M $
Gross Profit542.00K $
Net Income (TTM)-64.92M $
Revenue/Share0.0640 USD
Last Price6.410 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees69
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-7.80
PEG—
EV/EBITDA-9.85
EV/Revenue102.45
P/S113.37
P/B7.10
EPS (TTM)-0.57
EPS (Forward)-0.81
52W Range
1.52098% of range6.515
52W High6.515 USD
52W Low1.520 USD
Profitability
Gross Margin6.93%
Oper. Margin-1469.49%
EBITDA Margin0.00%
Profit Margin-829.58%
ROE-62.98%
ROA-40.46%
Growth
Revenue Growth-8.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-47.11M $
CapEx (TTM)111.00K $
FCF Margin-510.65%
FCF Yield-4.45%
Net Debt-89.71M $
Net Debt/EBITDA1.05
Balance Sheet
Debt/Equity1.49
Current Ratio3.46
Quick Ratio3.46
Book Value/Sh0.8910 USD
Cash/Share0.6220 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)10.20 USD
Upside (mean)+59.1%
Target Range4.000 USD – 16.00 USD
$4.000+59.1% to mean$16.00
# Analysts10
Ownership
Shares Out.147.20M
Float109.90M
Insiders2.18%
Institutions81.39%
Short Interest
Short Ratio7.5d
Short % Float10.62%
Short % Out.9.36%
Shares Short13.77M
Short (prev mo.)11.40M
Technical
SMA 505.393 (+18.9%)
SMA 2004.004 (+60.1%)
Beta0.78
S&P 52W Chg18.16%
Avg Vol (30d)1.71M
Avg Vol (10d)1.45M
Technical Indicators
RSI (14)66.0
MACD0.2707
MACD Signal0.2371
MACD Hist.+0.0336
BB Upper6.550 USD
BB Middle5.752 USD
BB Lower4.953 USD
BB Width27.77%
ATR (14)0.3275 USD
Vol Ratio (20d)1.34x